ADGM (Adagio Medical Holdings) Short Interest


ADGM Adagio Medical Holdings Inc ADGM
11 GF Score
Price $0.68
! 3 Warning Signs
View Full Analysis

What is Adagio Medical Holdings Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.


ADGM vs VNRX, PMI, SINT: Short Interest Comparison

For the Medical Devices subindustry, Adagio Medical Holdings's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adagio Medical Holdings Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Adagio Medical Holdings's Short Interest distribution charts can be found below:

* The bar in red indicates where Adagio Medical Holdings's Short Interest falls into.


ADGM
11GF Score
Adagio Medical Holdings Inc ADGM
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adagio Medical Holdings Business Description

Address 26051 Merit Circle, Suite 102, Laguna Hills, CA, USA, 92653
Adagio Medical Holdings Inc is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias with its proprietary, catheter-based Ultra-Low Temperature Ablation (ULTA) technology. UTLA is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The company is currently focused on the treatment of ventricular tachycardia (VT), a rapid, abnormal heart rhythm, or arrhythmia, that originates in the heart's lower chambers, or ventricles. The company has one reportable segment.
11GF Score

Get the complete analysis for ADGM

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.68
Price